CK-2017357

DRUG2 trials

Sponsors

Cytokinetics

Conditions

Amyotrophic Lateral Sclerosis

Phase 2

Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT01486849

CytokineticsAmyotrophic Lateral Sclerosis

Start: 2011-11-30End: 2012-03-31Updated: 2019-05-03

Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT01709149

CytokineticsAmyotrophic Lateral Sclerosis

Start: 2012-10-31End: 2014-03-31Updated: 2020-03-31